FcRider: a recombinant Fc nanoparticle with endogenous adjuvant activities for hybrid immunization is a research paper published in Antibody Therapeutics (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH Small Business Innovative Research
Grant: 75N93022C00011
NIH Small Business Innovative Research
Grant: 75N93022C00020
NIH/NIAID
Grant: R21AI168929
NIH/NIAID
Grant: 5R21AI173995
NIAID NIH HHS
Grant: R21 AI173995
National Institutes of Health
Grant: 1R21AI168929-01
Development of immunotherapeutic strategies and vaccines against multidrug resistant C. auris disseminated infection
National Institutes of Health
Grant: 1R21AI173995-01
Anopheles FBG: a novel malaria transmission-blocking vaccine target
Base&Byte Biotechnology Co., Ltd
Florida International University
Louisiana State University Health Sciences Center
FWCI
0.34
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals